Friday, November 20, 2015
Print Current Session:
|
|
Friday
SESSION 89:
NEW OR UPDATED CONCEPTS REGARDING VASCULAR TRAUMA, TAKAYASU’S DISEASE; AND MEDICAL TOPICS
Moderators:Richard J. Powell, MD / Vivian Gahtan, MD
|
|
SESSION 89 SCHEDULE | |
1:00 PM - 1:05 PM | Improving Outcomes Of Treatment For Major Trauma (Vascular And Other) With Aortic Balloon Control And Other Over The Wire Endovascular Techniques: The REBOA Registry And How Aortic Balloon Control Should Work |
Presenter(s):Tal M. Hörer, MD, PhD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA) With A Low Profile Not Over-A-Guide Wire: How Does It Work And Value In Military And Civilian Injuries |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Update On A Simplified Aortic Occlusion Balloon System For RAAAs, Major Vascular Or Other Hemorrhagic Trauma: Does It Require Fluoro And Who Can Use It |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | What Is The Role Of Endovascular Treatments In Takayasu’s Disease Of The Aorta And Its Branches |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Pitfalls In The Endovascular Treatment Of Takayasu’s Disease: Should They Ever Be Used And When |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Endovascular Treatments Should Be Used In Many Patients With Intermittent Claudication |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Not So: Exercise And Medical Therapy Are The Best Treatment For Almost All Patients With Intermittent Claudication |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | How To Predict Groin Wound Infections After Open Vascular Surgery: What Can Be Done To Prevent Them |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | DEBATE: Statins Are Disruptive Safe Miracle Drugs And Should Be Used More Widely: Which Drug, What Dose And For Whom |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | DEBATE: Not So: Statin Benefits Are Overblown And They Are Dangerous: They Should Be Used Less |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 89 | |
previous | next |